The Drug Controller General of India has suspended the manufacturing licence of PresVu eye drops Read on to know why it was suspended ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

The Drug Controller General of India (DCGI) has suspended the approval for PresVu, a drug that its maker Entod ...

In an order issued on Tuesday, the Drugs Controller General of India (DCGI) said it issued permission on August 20 to manufacture and market Pilocarpine Hydrochloride Ophthalmic Solution , the ...

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...

Mumbai-based Entod Pharmaceuticals said on Thursday that it has decided to move the court to challenge the national drug regulator’s suspension of permission to manufacture and market its pilocarpine ...

In an order issued on Tuesday, the drugs regulator said that the directorate had issued permission on August 20 for manufacture and marketing of Pilocarpine Hydrochloride Ophthalmic Solution for ...

Taking exception to Mumbai-based Entod Pharmaceuticals’ claims that its new eye drop can help reduce dependency on reading glasses for those suffering from presbyopia, the age-old related eye disorder ...